Navigation Links
Quest Diagnostics Reports Strong Revenue and Earnings Growth in First Quarter 2008
Date:4/21/2008

2.4 8.8

Cash and cash equivalents, beginning of period 167.6 149.6

Cash and cash equivalents, end of period $170.0 $158.4

Cash paid during the period for:

Interest $58.9 $20.3

Income taxes $24.8 $9.3

Notes to Financial Tables

1)The computation of basic and diluted earnings per common share is as

follows:

Three Months Ended

March 31,

2008 2007

Income from continuing operations $140.7 $107.5

Loss from discontinued operations (1.1) (1.6)

Net income available to common stockholders -

basic and diluted $139.6 $105.9

Weighted average common shares outstanding

- basic 194.1 193.4

Effect of dilutive securities:

Stock options, restricted common shares and

performance share units 1.7 1.9

Weighted average common shares outstanding -

diluted 195.8 195.3

Earnings per common share - basic:

Income from continuing operations $0.72 $0.56

Loss from discontinued operations - (0.01)

Net income $0.72 $0.55

Earnings per common share - diluted:

Income from continuing operations $0.72 $0.55

Loss from discontinued operations (0.01) (0.01)

Net incom
'/>"/>

SOURCE Quest Diagnostics Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. Vioxx Disclosure Emphasizes Need for New Web Resource that Answers Questions About Anti-Epileptic Medication Use
2. Susan G. Komen for the Cure Advocacy Alliance Suggests Questions for Tonights Presidential Debate
3. ImQuest Presents New Anti-HIV Drug and Topical Microbicide Development Results on Lead Pyrimidinedione Products IQP-0410 and IQP-0528
4. Quest Diagnostics to Release First Quarter 2008 Financial Results and Conduct Quarterly Investor Conference Call
5. New conference tackles the tough questions in lung cancer
6. The Quest for Americas Life in Beautiful Smiles: Captured in Photography
7. SurgiQuest Announces First Procedure Using AirSeal(TM) Access System
8. Study questions cost of complexity in evolution
9. Conseco Declines Partnerships Request for Board Seats; Review of Strategic Alternatives Underway
10. Large Disparities in Kidney Testing Based on Disease, Gender and State, Quest Diagnostics Health Trends(TM) Report Finds
11. Use of Methamphetamine Among U.S. Workers and Job Applicants Drops 22 Percent in 2007 and Cocaine Use Slows Dramatically, Reports Quest Diagnostics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)... Leukemia and myeloproliferative disorders are serious and ... the 51st Annual Meeting of the American Society ... improved diagnostic methods for patients suffering from acute ... leukemia, and myelofibrosis that are based on a ...
(Date:12/5/2009)... an innovative new international private medical insurance plan which follows the ... customers the flexibility to add or remove a wide range of ... to tailor their benefits to complement those already offered in their ... ...
(Date:12/4/2009)... Trust Inc. (NYSE: CRE ) ("Care" or the ... dividend of $0.17 per share of common stock. The dividend ... on December 14, 2009. ,, About Care ... estate investment and finance company investing in healthcare-related real estate and ...
(Date:12/4/2009)... The American Association of Homes and Services for the ... Community Living and Supportive Services (CLASS) provisions remain in the ... for providing support to elders, people with disabilities and their ... health care reform bill that will make it affordable to ...
(Date:12/4/2009)... Information Officer at Crescent Healthcare, was selected as a ... transforming Crescent,s business with the power of cloud computing. ... usage of Salesforce CRM or the Force.com platform in ... marketing, partner, service, support or IT organizations. ,, ...
Breaking Medicine News(10 mins):Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9Health News:AVIVA's Private Health Insurance Products Solutions Go International 2Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2
... State-of-the-art, remote monitoring and clinician notification system helps ... nursing facility patients safe and clinicians happy, ... inventor of Pulse CO-Oximetry and,Measure-Through-Motion-and-Low-Perfusion pulse oximetry, today ... remote monitoring,and clinician notification system outside of a ...
... lens meets highest standard for contact lens UV ... Brand,Contact Lenses for ASTIGMATISM, today became the fourth ... receive the AOA Seal of Acceptance for,Ultraviolet Absorbing ... Ophthalmic Standards. The announcement was made,in Seattle at ...
... ACM today announced the selection,of healthcare ... company,s new,Executive Vice President of Business Development. ... client service management, Ms.,Bryngelson will focus on ... -- including technology, call center operations,compliance, and ...
... be Installed in One of Canada,s Largest Academic ... Accuray,Incorporated (Nasdaq: ARAY ), a global leader ... Hospitalier de l,Universite de Montreal (CHUM),has purchased a ... du CHUM, in Montreal, Canada., CHUM, one ...
... coverage for most wound types, PRINCETON, N.J., ... a provider of advanced wound care products,announced today ... its key,product line, MEDIHONEY(TM) Wound & Burn Dressings, ... Active Leptospermum Honey packaged in a,tube, and a ...
... time is right and the,wording is excellent," said Brian ... the God-given Right to Life of every human,being and ... slaughter of,innocent children.", S.3111, introduced by Senator Roger ... debate in the Senate Committee on the Judiciary., ...
Other Medicine News:Health News:First Nursing Facility Installation of Masimo Patient SafetyNet(TM) Goes Live With 'Remarkable' Results 2Health News:First Nursing Facility Installation of Masimo Patient SafetyNet(TM) Goes Live With 'Remarkable' Results 3Health News:First Nursing Facility Installation of Masimo Patient SafetyNet(TM) Goes Live With 'Remarkable' Results 4Health News:First Nursing Facility Installation of Masimo Patient SafetyNet(TM) Goes Live With 'Remarkable' Results 5Health News:American Optometric Association Awards Acuvue(R) Oasys(TM) for Astigmatism With Seal of Acceptance for UV Absorbing Contact Lenses 2Health News:American Optometric Association Awards Acuvue(R) Oasys(TM) for Astigmatism With Seal of Acceptance for UV Absorbing Contact Lenses 3Health News:ACM Adds Top Industry Executive to Its Leadership Team 2Health News:First CyberKnife System to be Installed in Canada 2Health News:First CyberKnife System to be Installed in Canada 3Health News:First CyberKnife System to be Installed in Canada 4Health News:Derma Sciences Launches Two New MEDIHONEY(TM) Formulations 2Health News:Derma Sciences Launches Two New MEDIHONEY(TM) Formulations 3
(Date:12/4/2009)... 4 Thermographic Diagnostic Imaging (TDI), part of ... Jersey continues to provide superior quality infrared imaging ... and sinus regions to assist in the early ... ,, Thermography utilizes infrared imaging cameras that "read" ...
(Date:12/4/2009)... Amber Pharmacy announced today that it received accreditation ... for specialized pharmacy services. For nearly 15 years, Amber ... to meet the unique needs of specialized conditions. Amber ... to transplant programs. They work with over 170 transplant ...
(Date:12/4/2009)... LAKE CITY, Dec. 4 Dynatronics Corporation (Nasdaq: ... agreement to provide therapy equipment and rehab supplies to ... and Georgia. ,, "We are pleased to be ... Larry K. Beardall, executive vice president of sales and ...
Breaking Medicine Technology:Discover Health Through Awareness 2Discover Health Through Awareness 3Amber Pharmacy Earns Accreditation From ACHC 2WebMD Announces Second Quarter Financial Results 53286 1WebMD Announces Second Quarter Financial Results 53286 2WebMD Announces Second Quarter Financial Results 53286 3WebMD Announces Second Quarter Financial Results 53286 4WebMD Announces Second Quarter Financial Results 53286 5WebMD Announces Second Quarter Financial Results 53286 6WebMD Announces Second Quarter Financial Results 53286 7WebMD Announces Second Quarter Financial Results 53286 8WebMD Announces Second Quarter Financial Results 53286 9WebMD Announces Second Quarter Financial Results 53286 10WebMD Announces Second Quarter Financial Results 53286 11WebMD Announces Second Quarter Financial Results 53286 12WebMD Announces Second Quarter Financial Results 53286 13WebMD Announces Second Quarter Financial Results 53286 14WebMD Announces Second Quarter Financial Results 53286 15WebMD Announces Second Quarter Financial Results 53286 16WebMD Announces Second Quarter Financial Results 53286 17WebMD Announces Second Quarter Financial Results 53286 18WebMD Announces Second Quarter Financial Results 53286 19HLTH Corporation Announces Second Quarter Financial Results 53284 1HLTH Corporation Announces Second Quarter Financial Results 53284 2HLTH Corporation Announces Second Quarter Financial Results 53284 3HLTH Corporation Announces Second Quarter Financial Results 53284 4HLTH Corporation Announces Second Quarter Financial Results 53284 5HLTH Corporation Announces Second Quarter Financial Results 53284 6HLTH Corporation Announces Second Quarter Financial Results 53284 7HLTH Corporation Announces Second Quarter Financial Results 53284 8HLTH Corporation Announces Second Quarter Financial Results 53284 9HLTH Corporation Announces Second Quarter Financial Results 53284 10HLTH Corporation Announces Second Quarter Financial Results 53284 11HLTH Corporation Announces Second Quarter Financial Results 53284 12HLTH Corporation Announces Second Quarter Financial Results 53284 13HLTH Corporation Announces Second Quarter Financial Results 53284 14HLTH Corporation Announces Second Quarter Financial Results 53284 15HLTH Corporation Announces Second Quarter Financial Results 53284 16HLTH Corporation Announces Second Quarter Financial Results 53284 17HLTH Corporation Announces Second Quarter Financial Results 53284 18HLTH Corporation Announces Second Quarter Financial Results 53284 19HLTH Corporation Announces Second Quarter Financial Results 53284 20HLTH Corporation Announces Second Quarter Financial Results 53284 21HLTH Corporation Announces Second Quarter Financial Results 53284 22HLTH Corporation Announces Second Quarter Financial Results 53284 23Senesco Technologies Enters Into Agreements For Additional 24700 000 In Financing 13297 1Senesco Technologies Enters Into Agreements For Additional 24700 000 In Financing 13297 2Senesco Technologies Enters Into Agreements For Additional 24700 000 In Financing 13297 3Senesco Technologies Enters Into Agreements For Additional 24700 000 In Financing 13297 4Senesco Technologies Enters Into Agreements For Additional 24700 000 In Financing 13297 5
... Genotypically Optimized Dosing Results in Improved Tolerance,and ... Australia, and MENLO PARK, California U.S.A. June ... the presentation of data from its Quinamed ... a genotypically optimised dose of Quinamed in ...
... the , 2007 American Society of Clinical Oncology ... with AML and in,Refractory , ALL Patients Presented-- ... , the 5-HT3 Receptor Reported-- , --Results of ... Multimodal Therapy, including Gliadel(R) Described-- , --Survival Analysis ...
Other Medicine Technology:ChemGenex Reports Successful Personalized Dosing of Quinamed at,ASCO 2ChemGenex Reports Successful Personalized Dosing of Quinamed at,ASCO 3ChemGenex Reports Successful Personalized Dosing of Quinamed at,ASCO 4MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 2MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 3MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 4MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 5MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 6MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 7MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 8MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 9MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 10
... The LightCycler System is the ... The LightCycler System enables you to ... 30 min, and simultaneously quantify and ... during amplification. The unique Melting Curve ...
... PRISM 7900HT Sequence Detection System is ... detects and quantitates nucleic acid sequences. ... plate capability make the 7900HT system ... requirements of todays drug discovery process. ...
Sealing Mat for 96-well, 2.0ml, Deep Well, Square Available Sterile...
Sealing Mat for 96-well PCR Plate, Natural...
Medicine Products: